Literature DB >> 9291311

Peripheral blood from human immunodeficiency virus type 1-infected patients displays diminished T cell generation capacity.

D R Clark1, N M Ampel, C A Hallett, V R Yedavalli, N Ahmad, D DeLuca.   

Abstract

An organ culture chimera system was used to assess the effect of human immunodeficiency virus type 1 (HIV-1) infection on the T cell-generation capacity of precursors derived from human peripheral blood. Peripheral blood mononuclear cells from HIV-1-infected patients and uninfected controls were placed on fetal thymus lobes of NOD/LtSz-scid/scid mice. Blood from the HIV-1-infected patients consistently produced fewer CD4 and CD8 cells compared with blood from controls (P < .01). Addition of zidovudine to the cultures did not alter this profile. Limit dilution experiments suggested that there were fewer functional precursors in the infected patients. These results were not dependent on the patient's level of peripheral CD4 cells; even samples from patients with normal CD4 cell counts were unable to generate T cells in organ cultures. The results are consistent with a loss in the capacity of HIV-1-infected patients to produce functional T cell progenitors in their peripheral blood.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9291311     DOI: 10.1086/514086

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  5 in total

1.  In vivo HIV-1 infection of CD45RA(+)CD4(+) T cells is established primarily by syncytium-inducing variants and correlates with the rate of CD4(+) T cell decline.

Authors:  H Blaak; A B van't Wout; M Brouwer; B Hooibrink; E Hovenkamp; H Schuitemaker
Journal:  Proc Natl Acad Sci U S A       Date:  2000-02-01       Impact factor: 11.205

2.  HIV disease progression despite suppression of viral replication is associated with exhaustion of lymphopoiesis.

Authors:  Delphine Sauce; Martin Larsen; Solène Fastenackels; Michèle Pauchard; Hocine Ait-Mohand; Luminita Schneider; Amélie Guihot; Faroudy Boufassa; John Zaunders; Malika Iguertsira; Michelle Bailey; Guy Gorochov; Claudine Duvivier; Guislaine Carcelain; Anthony D Kelleher; Anne Simon; Laurence Meyer; Dominique Costagliola; Steven G Deeks; Olivier Lambotte; Brigitte Autran; Peter W Hunt; Christine Katlama; Victor Appay
Journal:  Blood       Date:  2011-03-24       Impact factor: 22.113

Review 3.  Assessing immune aging in HIV-infected patients.

Authors:  Victor Appay; Delphine Sauce
Journal:  Virulence       Date:  2016-06-16       Impact factor: 5.882

Review 4.  Incomplete immune recovery in HIV infection: mechanisms, relevance for clinical care, and possible solutions.

Authors:  Julie C Gaardbo; Hans J Hartling; Jan Gerstoft; Susanne D Nielsen
Journal:  Clin Dev Immunol       Date:  2012-03-14

5.  P2X7 Receptor Inhibition Improves CD34 T-Cell Differentiation in HIV-Infected Immunological Nonresponders on c-ART.

Authors:  Inna Menkova-Garnier; Hakim Hocini; Emile Foucat; Pascaline Tisserand; Laure Bourdery; Constance Delaugerre; Clarisse Benne; Yves Lévy; Jean-Daniel Lelièvre
Journal:  PLoS Pathog       Date:  2016-04-15       Impact factor: 6.823

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.